Hemolytic Uremic Syndrome. Clinical manifestations. Treatment;Sindrome uremico hemolitico manifestaciones clinicas. Tratamiento

Medicina

Volumn 66, Issue SUPPL. 3, 2006, Pages 6-10

  Exeni, Ramon A ^a  

^a Hospital de Ninos de San Justo   (Argentina)

Author keywords

Acute renal failure; Hemolytic anemia; Hemolytic uremic syndrome; Thrombocytopenia; Thrombotic microangiopathy

Indexed keywords

DIAZOXIDE; ENALAPRIL; LOSARTAN; NIFEDIPINE; NITROPRUSSIDE SODIUM; ESCHERICHIA COLI VACCINE;

ACUTE KIDNEY FAILURE; ARTICLE; BLOOD TRANSFUSION; CLINICAL FEATURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DISORDERS OF ACID BASE BALANCE; ELECTROLYTE DISTURBANCE; ENTEROPATHY; EPIDEMIC; HEART DISEASE; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPONATREMIA; KIDNEY TRANSPLANTATION; LEUKOCYTOSIS; METABOLIC ACIDOSIS; NEUROLOGIC DISEASE; PANCREAS DISEASE; PROGNOSIS; THROMBOCYTOPENIA; ACUTE DISEASE; CHILD; DIARRHEA; ESCHERICHIA COLI O157; FEMALE; IMMUNOLOGY; INFANT; MALE; PATHOPHYSIOLOGY; PRESCHOOL CHILD;

ACUTE DISEASE; CHILD; CHILD, PRESCHOOL; DIARRHEA; ESCHERICHIA COLI O157; ESCHERICHIA COLI VACCINES; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; HYPERTENSION; INFANT; KIDNEY FAILURE, ACUTE; KIDNEY TRANSPLANTATION; MALE; PROGNOSIS; THROMBOCYTOPENIA;

EID: 33845798663     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Exeni R, Grimoldi I, Amore A, Exeni A, et al. Low levels of serum erythropoietin in children with endemic HUS. Pediatr Nephrol 1998; 12: 226-30.
2. Gianantonio C, Vitaco M, Mendilaharzu F, Gallo G, Sojo E. Hemolytic Uremic Syndrome. J Pediatr 1964; 64: 478-91.
3. Exeni R, Grimoldi I, Antonuccio M, et al. Hemolytic uremic syndrome: our experience in 283 cases. Pediatr Nephrol 1998:12 C 179.
4. Repetto H. Epidemic HUS in children (Nephrology Forum). Kidney Int 1997; 52: 1708-19.
5. Kitov P, Sadowska J, George M, et al. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands. Nature 2000: 403: 669-72.
6. Mulvey G, Marcato P, Kitov P, Sadowska J, Bundle D, Armstrong G. Assessment in mice of the therapeutic potential of tailored shiga toxin carbohydrates ligands. J Infect Dis 2003; 187: 640-9.
7. Capozzo A, Pistone Creydt V, Dran G, et al. Development of DNA vaccines against hemolytic uremic syndrome in a murine model. Infect Immun 2003; 71: 3971-8.
8. Ahmed A, Li J, Shiloach V, Robbins J, Szu S. Safety and inmunogenicity of Escherichia coli 0157: H7 O-specific polysaccharide conjugate vaccine in 2-5-year-old children. J Infect Dis 2006; 193: 515-21.